Monica Ciupagea, UNODC

UNODC

Presenter Of 2 Presentations

Non-Commercial Satellite

Narrowing the gap in HIV harm reduction services, ‘HIV Prevention, Treatment, Care and Support Among People Who Use Stimulant Drugs’

Organizer
HIV/AIDS SectionUnited Nations Office on Drugs and Crime
Room
Satellite Channel 2

Moderator Of 2 Sessions

Non-Commercial Satellite

HIV prevention, treatment, care and support among people who use stimulant drugs

Organizer
HIV/AIDS SectionUnited Nations Office on Drugs and Crime
Room
Satellite Channel 2
Date
Thu, Jul 9, 2020
Time
11:00 AM - 12:00 PM
Session Description
For many years, the focus on HIV prevention among people who use drugs has concentrated on the injection of opiates. While it is difficult to quantify the contribution the use of stimulants is making to the increase in HIV rates, evidence points towards a positive association between stimulant use, higher-risk sexual and injecting behaviors and HIV.CHAR(13) + CHAR(10)The overlapping risks between key populations are not sufficiently addressed by current interventions.CHAR(13) + CHAR(10)Participants in the session will learn about how to address HIV among people who use stimulant drugs focusing on specific key populations (Men having Sex with Men, People Who Inject Drugs, Sex Workers, Transgender people).CHAR(13) + CHAR(10)a) Overview of the epidemiological situation related to HIV and stimulant drug useCHAR(13) + CHAR(10)b) Barriers and opportunities for addressing the specific needs of the key populationsCHAR(13) + CHAR(10)c) UNODC guide "HIV Prevention, Treatment, and Care for People Who Use Stimulant Drugs"
Non-Commercial Satellite
Organizer
HIV/AIDS SectionUnited Nations Office on Drugs and Crime
Room
Satellite Channel 2
Date
Thu, Jul 9, 2020
Time
11:00 AM - 12:00 PM
Session Description
For many years, the focus on HIV prevention among people who use drugs has concentrated on the injection of opiates. While it is difficult to quantify the contribution the use of stimulants is making to the increase in HIV rates, evidence points towards a positive association between stimulant use, higher-risk sexual and injecting behaviors and HIV. Both non-injecting and injecting stimulant drug use has been associated with sexual transmission of HIV, particularly among men who have sex with men and sex workers. The overlapping risks between key populations are not sufficiently addressed by current interventions. Participants in the session will learn about how to address HIV among people who use stimulant drugs focusing on specific key populations (Men having Sex with Men, People Who Inject Drugs, Sex Workers, Transgender people). a) Overview of the epidemiological situation related to HIV and stimulant drug use b) Barriers and opportunities for addressing the specific needs of the key populations c) UNODC guide "HIV Prevention, Treatment, and Care for People Who Use Stimulant Drugs"

Presenter Of 2 Presentations

Non-Commercial Satellite

Narrowing the gap in HIV harm reduction services, ‘HIV Prevention, Treatment, Care and Support Among People Who Use Stimulant Drugs’

Organizer
HIV/AIDS SectionUnited Nations Office on Drugs and Crime
Room
Satellite Channel 2

Moderator Of 1 Session

Non-Commercial Satellite
Organizer
HIV/AIDS SectionUnited Nations Office on Drugs and Crime
Room
Satellite Channel 2
Session Description
For many years, the focus on HIV prevention among people who use drugs has concentrated on the injection of opiates. While it is difficult to quantify the contribution the use of stimulants is making to the increase in HIV rates, evidence points towards a positive association between stimulant use, higher-risk sexual and injecting behaviors and HIV. Both non-injecting and injecting stimulant drug use has been associated with sexual transmission of HIV, particularly among men who have sex with men and sex workers. The overlapping risks between key populations are not sufficiently addressed by current interventions. Participants in the session will learn about how to address HIV among people who use stimulant drugs focusing on specific key populations (Men having Sex with Men, People Who Inject Drugs, Sex Workers, Transgender people). a) Overview of the epidemiological situation related to HIV and stimulant drug use b) Barriers and opportunities for addressing the specific needs of the key populations c) UNODC guide "HIV Prevention, Treatment, and Care for People Who Use Stimulant Drugs"

Presenter Of 2 Presentations

Non-Commercial Satellite

Narrowing the gap in HIV harm reduction services, ‘HIV Prevention, Treatment, Care and Support Among People Who Use Stimulant Drugs’

Organizer
HIV/AIDS SectionUnited Nations Office on Drugs and Crime
Room
Satellite Channel 2

Moderator Of 2 Sessions

Non-Commercial Satellite

HIV prevention, treatment, care and support among people who use stimulant drugs

Organizer
HIV/AIDS SectionUnited Nations Office on Drugs and Crime
Room
Satellite Channel 2
Session Description
For many years, the focus on HIV prevention among people who use drugs has concentrated on the injection of opiates. While it is difficult to quantify the contribution the use of stimulants is making to the increase in HIV rates, evidence points towards a positive association between stimulant use, higher-risk sexual and injecting behaviors and HIV.CHAR(13) + CHAR(10)The overlapping risks between key populations are not sufficiently addressed by current interventions.CHAR(13) + CHAR(10)Participants in the session will learn about how to address HIV among people who use stimulant drugs focusing on specific key populations (Men having Sex with Men, People Who Inject Drugs, Sex Workers, Transgender people).CHAR(13) + CHAR(10)a) Overview of the epidemiological situation related to HIV and stimulant drug useCHAR(13) + CHAR(10)b) Barriers and opportunities for addressing the specific needs of the key populationsCHAR(13) + CHAR(10)c) UNODC guide "HIV Prevention, Treatment, and Care for People Who Use Stimulant Drugs"
Non-Commercial Satellite
Organizer
HIV/AIDS SectionUnited Nations Office on Drugs and Crime
Room
Satellite Channel 2
Session Description
For many years, the focus on HIV prevention among people who use drugs has concentrated on the injection of opiates. While it is difficult to quantify the contribution the use of stimulants is making to the increase in HIV rates, evidence points towards a positive association between stimulant use, higher-risk sexual and injecting behaviors and HIV. Both non-injecting and injecting stimulant drug use has been associated with sexual transmission of HIV, particularly among men who have sex with men and sex workers. The overlapping risks between key populations are not sufficiently addressed by current interventions. Participants in the session will learn about how to address HIV among people who use stimulant drugs focusing on specific key populations (Men having Sex with Men, People Who Inject Drugs, Sex Workers, Transgender people). a) Overview of the epidemiological situation related to HIV and stimulant drug use b) Barriers and opportunities for addressing the specific needs of the key populations c) UNODC guide "HIV Prevention, Treatment, and Care for People Who Use Stimulant Drugs"